New Partnership Launches to Empower People Diagnosed With Lymphoma


Get Permission

With this new initiative, our goal is to empower people with lymphoma to be active partners in their care, and ensure they don’t feel isolated in their journey.

—Louis J. DeGennaro, PhD

The Leukemia & Lymphoma Society (LLS), together with the Lymphoma Research Foundation (LRF), CancerCare, the Association of Community Cancer Centers (ACCC), and Genentech announced the launch of a new partnership, the Alliance for Resource Collaboration in Hematology (ARCH). ARCH was developed by these five leading organizations to connect people with lymphoma, their caregivers, and loved ones to educational resources and support.

“Many people diagnosed with lymphoma, particularly in community cancer programs, are unaware of all the resources available to them,” said Louis J. DeGennaro, PhD, LLS’s President and Chief Executive Officer. “With this new initiative, our goal is to empower people with lymphoma to be active partners in their care, and ensure they don’t feel isolated in their journey.”

By visiting www.LymphomaResources.com, people can connect to the partner organizations to learn about the different types of lymphoma, explore treatment options, find information about specialists, and search financial support options. The ARCH website also helps in finding patient communities, peer support programs, and counseling services. The partner organizations provide these resources in a variety of formats, including in-person programs, online materials, and telephone support.

It is estimated that only 15% of U.S. cancer patients are treated at the nation’s major academic cancer centers; the vast majority receive care at cancer programs in or near their home community, where resources may be more limited. By bringing together ACCC’s network of community cancer programs with the quality resources provided by LLS, LRF and CancerCare, ARCH aims to have an immediate impact on access to information for lymphoma patients where the need is greatest. ■



Advertisement

Advertisement



Advertisement